Clinical Trials Logo

Clinical Trial Summary

Voltaren being a Non-steroidal anti-inflammatory drug (NSAID) drug may be used as a single drug therapy in otitis externa being both therapeutic and analgesic thus reducing consumption of oral analgesia.


Clinical Trial Description

anticipated advantages are: reduction of inflammation and edema, no fungal overpopulation- when steroids are employed, contains boric acid as an ingredient, high safety profile, can be switched to antibiotic therapy later, can be used in conjunction wit steroids ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00523120
Study type Interventional
Source Sieff Medical Center
Contact
Status Terminated
Phase Phase 2
Start date September 2008
Completion date December 2011

See also
  Status Clinical Trial Phase
Completed NCT00872209 - Safety and Efficacy Study of Foam Otic Cipro Compared to a Standard Solution ( Ciloxan - Alcon Labs ) to Treat Acute Otitis Externa Phase 1/Phase 2
Recruiting NCT05370209 - Performance and Safety of Otinova® Ear Spray N/A
Completed NCT02558738 - Non Interventional Clinical Investigation of Ectoin Ear Spray in Skin Treatment of Outer Ear Canal Irritations N/A
Completed NCT02511561 - OTO-201 for the Treatment of Otitis Externa Phase 2
Terminated NCT01910155 - A Bioequivalence Study of Two Ciprofloxacin/Dexamethasone Formulations in Patients With Otitis Externa Phase 3
Completed NCT01359098 - Efficacy and Safety of Once-Daily Ciprodexa Otic Foam Compared to Twice-daily Ciprodex Ear Drops in Acute Otitis Externa Phase 2
Completed NCT01157819 - Safety and Efficacy of Once-Daily Dosing of FoamOtic Cipro Compared to Twice-Daily Dosing of Ciloxan Ear Drops in Patients With Acute External Otitis Phase 2
Completed NCT00980876 - A Comparative Study Between Two Formulations of the Ciprofloxacin Hydrochloride + Hydrocortisone Otic Suspension Phase 3